Viracta Therapeutics, Inc. earnings per share and revenue

VIRX earnings per share for the last quarter are -0.27 USD whereas the estimation was -0.27 USD which accounts for -1.25% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.16 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of VIRX earnings per share and revenue dynamics.